On 1st April 2021, the PAYE/NIC cap on payable credits came into force. Here's our guide on how this affects SME R&D tax relief claims.
The cap applies to any accounting periods beginning after 1st April 2021. Claims for R&D tax made for accounting periods longer than 12 months that straddle 1st April 2021 will need to consider the cap for the period that starts after this date. For example, for a period of account of 18 months starting on 1 January 2021, the cap would be applicable from the accounting period starting 1 January 2022.
The amount of payable tax credit that an SME can claim is capped to £20,000 plus 300% of the company’s total PAYE and NIC liability for the period. So if a company has paid out, for example, £50,000 in PAYE/NICs in the claim year, the maximum tax credit it can claim is £170,000. This equates to a surrenderable loss of over £1m, and an eligible spend of £500-£900k. This is a huge amount for a company of 10-20 staff to spend, so you can see that the cap is unlikely to affect companies with more than a few staff.
The most affected companies will be small, loss-making start-ups who spend a lot on subcontractors. For example, a company with two directors on minimum salaries won’t pay anything out on NICs or PAYE. In this scenario, assuming that they make a loss for the year, the maximum tax credit they’d be able to claim is £20k (approximately £60-100k eligible spend).
The cap only applies to companies that are either loss making, or those that create a loss through the R&D enhancement, and who want to surrender the loss for a payable cash credit. It won’t affect the reductions in tax liability available to profitable companies, or companies that choose to carry forward losses rather than surrendering them.
A company is exempt from the cap if it is creating or managing IP, and less than 15% of the eligible expenditure is on subcontracting to or EPWs from connected persons. The legislation defines IP as anything from a patent to know-how generated during the R&D project, so this is very wide, and HMRC's own guidance states that any company carrying out R&D should meet the criteria of creating IP.